Nea Management Company, LLC Imara Inc. Transaction History

Nea Management Company, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.99 - $1.87 $2.28 Million - $4.3 Million	-2,301,371 Reduced 69.57%	1,006,722 $1.23 Million
Q1 2022 May 16, 2022	SELL	$1.15 - $2.41 $320,019 - $670,649	-278,278 Reduced 7.76%	3,308,093 $6.22 Million
Q4 2021 Feb 14, 2022	SELL	$2.25 - $4.05 $969,297 - $1.74 Million	-430,799 Reduced 10.72%	3,586,371 $8.07 Million
Q1 2020 May 06, 2020	BUY	$15.0 - $16.6 $60.3 Million - $66.7 Million	4,017,170 New	4,017,170 $64.4 Million

104K

170K

Ticker IMRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,287,300
Market Cap $552M
Description
IMARA Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develop...

Get notified when there are updates to the investment portfolio of Nea Management Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Nea Management Company, LLC with notifications on news.